Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...

Descripción completa

Detalles Bibliográficos
Autores principales: Munchel, Ashley, Kesserwan, Chimen, Symons, Heather J., Luznik, Leo, Kasamon, Yvette L., Jones, Richard J., Fuchs, Ephraim J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206539/
https://www.ncbi.nlm.nih.gov/pubmed/22053277
http://dx.doi.org/10.4081/pr.2011.s2.e15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206539/
https://www.ncbi.nlm.nih.gov/pubmed/22053277
http://dx.doi.org/10.4081/pr.2011.s2.e15

Ejemplares similares